The relative function of the P2X7 receptor, an ATP-gated ion channel, varies between humans due to polymorphisms in the P2RX7 gene. This study aimed to assess the functional impact of P2X7 variation in a random sample of the canine population. Blood and genomic DNA were obtained from 69 dogs selected as representatives of a cross section of different breeds. P2X7 function was determined by flow cytometric measurements of dye uptake and patch-clamp measurements of inward currents. P2X7 expression was determined by immunoblotting and immunocytochemistry. Sequencing was used to identify P2RX7 gene polymorphisms. P2X7 was cloned from an English springer spaniel, and point mutations were introduced into this receptor by site-directed mutagenesis. The relative function of P2X7 on monocytes varied between individual dogs. The canine P2RX7 gene encoded four missense polymorphisms: F103L and P452S, found in heterozygous and homozygous dosage, and R270C and R365Q, found only in heterozygous dosage. Moreover, R270C and R365Q were associated with the cocker spaniel and Labrador retriever, respectively. F103L, R270C, and R365Q but not P452S corresponded to decreased P2X7 function in monocytes but did not explain the majority of differences in P2X7 function between dogs, indicating that other factors contribute to this variability. Heterologous expression of site-directed mutants of P2X7 in human embryonic kidney-293 cells indicated that the R270C mutant was nonfunctional, the F103L and R365Q mutants had partly reduced function, and the P452S mutant functioned normally. Taken together, these data highlight that a R270C polymorphism has major functional impact on canine P2X7.
INTRODUCTION
Since the partial (31) and complete (33) sequencing of the canine genome there has been considerable interest in the use of single nucleotide polymorphisms (SNPs) to help explain the ancestry and evolutionary origins of the domestic dog (Canis lupus familiaris) (33, 53) , as well as the phenotypic diversity between breeds (9) . Moreover, as exemplified by recent studies (30, 46) , there is continual interest in identifying SNPs associated with breed--specific disorders to determine the causes of such disorders in dogs and to help elucidate the mechanisms involved in similar disorders within humans. One study that supports this approach has been a genome--wide association analysis, which identified a SNP within the gene coding canine Cu/Zn SOD in breeds susceptible to degenerative myelopathy (3); a disease similar to amyotrophic lateral sclerosis in humans, which is also associated with SNPs in the gene coding human Cu/Zn SOD (43) . This approach however is currently restricted.
First, presumably not all SNPs have been identified in the some 350 breeds that exist. Second, as for humans the molecular and cellular effects of most canine SNPs identified to date are yet to be fully elucidated. Thus, there is a need to identify novel SNPs within the dog, and to define how these and existing SNPs influence canine biology.
The P2X7 receptor is a trimeric ligand--gated ion channel present on various cell types, with high amounts present on the cell--surface of monocytes (54) . Upon activation by its natural ligand ATP, the P2X7 channel rapidly opens and dilates to form a pore to allow the flux of organic cations and anions including fluorescent dyes (11) . P2X7 activation also results in a variety of downstream events including the release of pro--inflammatory mediators such as IL--1β, PGE2 and CXC chemokine ligand 16 (4, 38, 40) . Conversely in the absence of ATP, P2X7 may function as a scavenger receptor to facilitate the phagocytosis of bacteria and apoptotic cells (23) . As a result of these and other observations, P2X7 is attracting considerable interest as a therapeutic target in various immune--mediated disorders and pain (36) . P2X7 activation is also important in physiological systems other than the immune system such as bone homeostasis (52) , and carbohydrate and lipid metabolism (2, 6) .
The human, canine, rhesus macaque, rat and murine P2X7 subunits have been cloned (10, 12, 41, 42, 51) . Each of these mammalian P2X7 subunits are 595 amino acids in length, and comprise intracellular N--and C--termini, two trans--membrane domains and a large extracellular loop. The P2X7 subunit is encoded by the P2RX7 gene, which comprises 13 exons and is highly polymorphic in humans, resulting in at least 12 loss--of--function and three gain--of--function receptor variants (45) . A loss--of--function SNP, P451L (rs48804829), has also been described in mouse P2X7 (1) , but descriptions of SNPs in the P2RX7 gene from other species are limited.
Some 40 years ago, Parker and Snow demonstrated that extracellular ATP could
increase the membrane permeability of Beagle erythrocytes to cations (37) . Nearly 30 years later, our group using erythrocytes from English Springer Spaniels, identified that this effect was mediated by P2X7 (44) , providing the first direct evidence that functional P2X7 receptors are present within dogs. Subsequently our group demonstrated that P2X7 was also present on monocytes, B cells and T cells from this (44, 48) , and more recently from other dog breeds (25, 47) . However, the dog breeds in which P2X7 has been studied are limited, and thus it remains unknown if P2X7 function varies between dogs or breeds. Two missense (non--synonymous) SNPs, F103L (rs23314713) and P452S (rs23315462), as well as one synonymous SNP N131N (rs8660017) in the canine P2RX7 gene have been reported in databases of Ensembl (http://www.ensembl.org/index.html) or the National Centre for Biotechnology Information (NCBI; http://www.ncbi.nlm.nih.gov/snp). However, the functional effects of these SNPs remain unknown. The current study describes that the relative P2X7 function varies between dogs. Moreover, the current study confirms the presence of the F103L and P452S SNPs in canine P2X7, and identifies three other missense SNPs, R270C, R365Q and L440F. Finally, using a recombinant P2X7, cloned from an English Springer Spaniel, the current study demonstrates that the R270C SNP results in near complete loss of function of canine P2X7.
MATERIALS AND METHODS
Materials. Ficoll--Paque PLUS was from GE Healthcare Biosciences (Uppsala, Sweden). Fluorescent Particles were from Spherotech (Lake Forest, IL). Primers for sequencing were obtained from GeneWorks (Hindmarsh, Australia). MangoTaq DNA polymerase was from Bioline (London, UK). Primers for cloning were from Sigma Life Science (Castle Hill, Australia). PfuUltra High--Fidelity DNA polymerase was from Stratagene (La Jolla, CA). NheI and NotI restriction enzymes were from Fermentas (Glen Burnie, MD). FBS was from Bovogen Biologicals (East Keilor, Australia). Ethidium bromide was from Amresco (Solon, OH). Rabbit anti--mouse P2X7 (extracellular epitope) polyclonal antibody (Ab) and blocking peptide, and rabbit anti--rat P2X7 (C--terminal epitope) Ab were from Alomone Labs (Jerusalem, Israel).
A438079, AZ10606120 and AZ11645373 were from Tocris Bioscience (Ellisville, MO). KN--62 was from Alexis Biochemicals (Lausen, Switzerland).
Samples. All canine samples were collected from privately owned dogs presented at local veterinary clinics with informed consent of owners. All samples were collected in accordance with institutional guidelines, and with approval from the Animal and Human Ethics Committees of the University of Wollongong (Wollongong, Australia).
YO--PRO--1 2+ uptake into canine monocytes. Peripheral blood was collected into VACUETTE lithium heparin tubes (Greiner Bio--One, Frickenheisen, Germany) from either pedigree or cross breed dogs. Peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats using Ficoll--Paque density centrifugation as described (48) and used as a template to clone canine P2X7 using standard techniques. Canine P2X7 cDNA was amplified by PCR using PfuUltra High--Fidelity DNA polymerase and the product was cloned into the NheI/NotI sites of a pHumanP2X7--AcGFP--N1 plasmid (49) , from which human P2X7--AcGFP had been removed by double digestion with NheI/NotI. The sequence of the resulting plasmid containing canine P2X7, pEnglish Springer Spaniel P2X7, was determined using four overlapping forward and reverse primer pairs (5' to 3': CCGCCTGGTGTCCCATCG and ATCTTCTTGATTCCATTCTCC; CCACCTCAGAGCCGTTCA and CAGCTGCATCTCCTCTG;
TGGCACCATTAAGTGGAT and GGTTCTGAGTCTTGTGAAAGGT; AGACAATTGTGGAGCCAA and CTAGGTCCTGGGAGCCAAAG) with the ABI PRISM BigDye Terminator v3.1 Cycle Sequencing Kit and an Applied Biosystems 3130xl Genetic Analyzer. Resulting sequences were compared to the NCBI Reference Sequence NM_001113456.1, the earlier NCBI Reference Sequence XM_534669.2 (originally obtain from a Boxer as part of the canine genome project) (33) and to the sequence of P2X7 previously cloned from heart cDNA of a non--disclosed dog breed (42) . Plasmid DNA was isolated using the Wizard Plus SV Minipreps DNA Purification System and MDCK cells were maintained in DMEM/F12 medium supplemented with 10% FBS, 2 mM GlutaMAX, 100 U/mL penicillin and 10 μg/mL streptomycin (complete culture medium) at 37 o C/5% CO2. Murine microglial EOC13 cells were maintained as described (5). Immunoblotting. Whole lysates of HEK--293 or EOC13 cells were prepared as described (13) . Equal amounts of total protein were separated under reducing conditions using Any kD Mini--PROTEAN TGX Stain--Free Gels and transferred to nitrocellulose membrane using a Trans--Blot Turbo Transfer System (all Bio--Rad, Hercules, CA). Immunoblotting was performed with an anti--P2X7 polyclonal Ab as described (13) . To confirm equal protein loading within stain--free gels, total protein was measured using a Bio--Rad Criterion Stain Free Imager and Image Lab software. P2X7 (75 kDa) was detected using Amersham Hyperfilm ECL (GE Healthcare, Little Chalfont, UK), and relative P2X7 expression was measured using a Bio--Rad GS--800 Densitometer and ImageJ software (http://rsbweb.nih.gov/ij/).
Site--directed mutagenesis. Missense SNPs were introduced into pEnglish Springer
Spaniel P2X7 using standard techniques and confirmed by sequencing (SUPAMAC, Sydney, Australia) as described previously (49) .
Immunocytochemistry. Immunolabeling of non--permeabilized cells was performed with an anti--mouse P2X7 polyclonal Ab as described (5) . Cells were visualized using a TCS SP5 II confocal imagining system (Leica, Mannheim, Germany) (excitation at 561 nm; emission collected at 575--630 nm).
Electrophysiology. Whole cell patch--clamp recordings of HEK--293 cells were performed in low divalent solution (145 mM NaCl, 5 mM KCl, 0.2 mM CaCl2, 13 mM glucose, 10 mM HEPES, pH 7.3, osm 295--310) and recorded using a HEKA (Lambrecht, Germany) EPC10 amplifier as described (7). genotypes were compared using the Mann--Whitney test or the Kruskal--Wallis test (using Dunn's multiple comparison test). Statistical comparisons were made using Prism 5 (GraphPad Software, San Diego, CA) with P<0.05 considered significant.
RESULTS
To determine if the relative P2X7 function varied between dogs, blood was obtained from dogs presented at local veterinary clinics and the ATP--induced uptake of YO--PRO--1 2+ into CD14 + monocytes determined by flow cytometry. Calibration beads were used to set the 515/20 nm detector of the flow cytometer for each sample. ATP induced YO--PRO--1 2+ uptake into monocytes from all 52 dogs studied, with an average MFI of 152 ± 97 (Fig. 1) . Relative P2X7 function varied between dogs. Within individual breeds where three or more dogs were studied, relative P2X7 function varied by at least two--fold in both American Bull Terriers and Staffordshire Bull Terriers, and up to 13--fold in Labrador Retrievers (Fig. 1) . Similarly, relative P2X7 varied amongst cross breed dogs with a 13--fold difference in P2X7 function between monocytes from a Border Collie and Australian Cattle Dog cross, and from a Golden Retriever and Labrador Retriever cross, which had the highest (MFI of 395) and lowest (MFI of 31) P2X7 function, respectively (Fig. 1) . In contrast to canine monocytes, ATP was unable to induce YO--PRO--1 2+ uptake in MDCK cells over 5 min (MFI of 0; Fig. 1 ).
To determine if the variation in P2X7 function between dogs was attributed to SNPs in the P2RX7 gene, the 13 exons of this gene from 19 dogs with either low or high P2X7 function, as well as from MDCK cells were sequenced. Sequences were compared to the NCBI Reference Sequence NM_001113456.1, which was designated as the wild--type canine P2X7 sequence.
Sequencing confirmed the existence of the two previously reported missense SNPs, rs23314713 (ttc>ctc) in exon 3 and rs23315462 (cct>tct) in exon 13, which code for the amino acid substitutions F103L and P452S, respectively ( Fig. 2A ; Table 2 ). Sequencing also confirmed the existence of the previously reported synonymous SNP rs8660017 (aat>aac;
N131N) in exon 4 of 14 dogs in either heterozygous (n=6) or homozygous dosage (n=8) (results not shown). Finally, sequencing identified two novel missense SNPs, cgt>tgt in exon 8
and cga>caa in exon 11, which code for the amino acid substitutions R270C and R356Q, respectively ( Fig.  2A ; Table  2 ). Complete sequences were obtained from all exons except for exon 13, for which the 48 base pairs coding the last 16 amino acid residues of the C--terminus of P2X7 could not be resolved due to poor signal--to--noise ratio (results not shown). (Table 2) . Notably, the R270C SNP was only observed in a Cavalier King Charles Spaniel and Cocker Spaniel cross and in MDCK cells, which were originally derived from a Cocker Spaniel (16) . In both instances the R270C SNP was present in heterozygous dosage, and appeared to be linked with the P452S SNP ( Table 2 ). The R270C SNP was not observed in a second Cocker Spaniel cross, from which no functional data was available (Table 2 ). The R365Q SNP was only observed in three Labrador Retrievers and in a Golden Retriever and Labrador Retriever cross, and then only in heterozygous dosage in all four cases; three other Labrador Retrievers were wild--type at residue position 365 ( Table 2) .
The relative P2X7 function obtained above (Fig. 1) was then compared to each missense SNP individually. The P2X7 function of dogs heterozygous for the F103L SNP was similar to that of dogs wild--type for F103, however the P2X7 function of dogs homozygous for this SNP was significantly lower compared to wild--type animals (Fig. 2B) . Sample numbers were limited for both the R270C and R365Q SNPs, and were only observed in heterozygous dosage, but the mean P2X7 function in dogs with either of these SNPs was about half that of the mean P2X7 function in dogs wild--type for R270 or R365 (Fig. 2B) . In contrast, mean P2X7 function was similar between dogs wild--type for P452, or heterozygous or homozygous for the P452S SNP (Fig. 2B) .
Our group has previously characterized P2X7 in erythrocytes and leukocytes from English Springer Spaniels (44, 48) . Therefore, P2X7 was cloned using cDNA from this breed to generate a recombinant P2X7 for site--directed mutagenesis studies. The cloned receptor was 595 amino acids in length (results not shown) and was wild--type at amino acid positions 103 (F103), 270 (R270) and 365 (R365) (Fig. 3A) compared to the (wild--type) NCBI Reference Sequence NM_001113456.1. In contrast, the cloned receptor differed at amino acid positions 440 (L440F; ttg>ttt) and 452 (P452S; cct>tct) (Fig. 3A) . (Fig. 3D) .
The recombinant English Springer Spaniel P2X7 expressed heterologously in HEK--293 cells was further characterized using flow cytometric measurements of ethidium + uptake. ATP induced ethidium + uptake in a concentration--dependent fashion with an EC50 value of 253 µM (Fig. 3E) . Moreover, BzATP and ATPγS, agonists of endogenous and recombinant human P2X7 (15, 19) , induced ethidium + uptake in a concentration--dependent fashion and with EC50 values of 13 and 438 µM, respectively (Fig.  3E) . Maximum ethidium + uptake was observed with 50 µM BzATP, while ATP and ATPγS represented partial agonists. In contrast, ADP, UTP and αβ--meATP (each at 1 mM) failed to induce ethidium + uptake (Fig. 3E) .
The efficacy of five well--known human and rodent P2X7 antagonists was then tested against the recombinant English Springer Spaniel P2X7. A438079 (35) (Fig. 3F) . Moreover, all five antagonists completely impaired ATP--induced ethidium + uptake with maximal inhibition observed at concentrations of 0.1 µM for AZ10606120 and AZ11645373, 1 µM for KN--62, and 10 µM for A438079 and BBG (Fig. 3F ).
To determine if any of the missense SNPs identified above (F103L, R270C, R365Q, L440F and P452S) effect P2X7 function, the cloned English Springer Spaniel P2X7 was mutated as follows. First, the plasmid containing the cloned English Springer Spaniel P2X7 (which contained both the 440F and 452S SNPs; now termed 440F/452S mutant P2X7) was changed to wild--type at position 440 (termed 452S mutant P2X7) by mutating the phenylalanine residue to leucine. Next, the plasmid containing only the 452S SNP was either changed to wild--type P2X7 (termed wild--type P2X7) by mutating the serine residue at position 452 to proline or changed to a double mutant (termed 270C/452S mutant P2X7) by mutating the arginine residue at position 270 to cysteine. Finally, the wild--type P2X7 plasmid was mutated to contain either the 103L or 365Q SNP (termed 103L and 365Q mutant P2X7, respectively).
Using the above plasmids, the effect of each SNP on P2X7 function assessed by measurements of ATP--induced ethidium + uptake into transfected HEK--293 cells. ATP--induced ethidium + uptake was 24% less in cells expressing 452S mutant P2X7 compared to cells expressing 440F/452S mutant P2X7 (Fig. 4A) . ATP--induced ethidium + uptake into cells expressing 452S mutant P2X7 was similar to that of cells expressing wild--type P2X7 (Fig. 4B) .
In contrast, ATP--induced ethidium + uptake was almost completely abolished in cells expressing 270C/452S mutant P2X7 compared to cells expressing either wild--type or 452S mutant P2X7 (Fig. 4B) . Finally, ATP--induced ethidium + uptake was 46% and 37% less in cells expressing either 103L or 365Q mutant P2X7, respectively compared to cells expressing wild--type P2X7 (Fig. 4C) .
To determine if the differences in ATP--induced ethidium + uptake in transfected HEK--293 cells related to total P2X7 expression, whole lysates of HEK--293 cells transfected with DNA from wild--type or each mutant P2X7 plasmid were examined by immunoblotting using the Ab against the extracellular epitope of P2X7 and the amount of P2X7 quantified. As above (Fig.  3B) , a major band at 75 kDa was detected in lysates of HEK--293 cells expressing wild--type or mutant P2X7 (Fig. 4D--F) . The amount of P2X7 was 29% less in cells expressing the 452S mutant compared to cells expressing 440F/452S mutant P2X7 (Fig.  4D) . The amount of P2X7 was 22% and 30% less in cells expressing either 452S or 270C/452S mutant P2X7 respectively compared to cells expressing wild--type P2X7 (Fig.  4E) . The amount of P2X7 was 48% and 32% less in cells expressing either 103L or 365Q mutant P2X7 respectively compared to cells expressing wild--type P2X7 (Fig. 4F) .
The above data indicates that the R270C SNP has a major functional impact on canine P2X7. Therefore, this SNP was characterised further in HEK--293 cells expressing either wild--type, 452S or 270C/452S mutant P2X7. First, patch--clamp measurements revealed that ATP induced robust inward currents in HEK--293 cells expressing wild--type or 452S mutant P2X7, with mean current densities of 49 (19) pA/pF (n=6) and 39 (24) pA/pF (n=7), respectively and which were not significantly different (P>0.05) (Fig. 5A) . In contrast, ATP--induced inward currents in HEK--293 cells expressing 270C/452S mutant P2X7 were significantly smaller (mean current density of 3 (1) pA/pF, n=5) than those observed in HEK--293 cells expressing wild--type or 452S mutant P2X7 (P<0.01 and P<0.05, respectively) (Fig. 5A ). In addition, multiple applications of ATP saw wild--type or 452S mutant P2X7 display facilitation of responses over 5 min, whereas 270C/452S mutant P2X7 responses did not display facilitation and remained small (Fig. 5B) . Second, immunolabeling with an Ab specific for the extracellular loop of P2X7 and confocal microscopy demonstrated cell--surface expression of P2X7 on HEK--293 cells expressing wild--type, 452S or 270C/452S mutant P2X7 (Fig. 6) . In 
DISCUSSION
The current study aimed to assess the functional impact of P2X7 variation in a random sample of the canine population. Others and us have previously shown that monocyte P2X7 function correlates with P2RX7 genotype in humans (14, 24, 49) . Thus, the variable P2X7 function between dog breeds and within individual breeds may in part be caused by SNPs within the canine P2RX7 gene. Of the P2RX7 SNPs identified F103L, R270C and R365Q, but not P452S, corresponded to decreased P2X7 function in canine monocytes. However these SNPs could not explain the majority of differences in P2X7 function between dogs, indicating that other factors contribute to this variability. Such factors may include SNPs in the last 48 base pairs of exon 13 and in the promoter and intronic regions of the P2RX7 gene, differential expression of P2X7 splice variants, or differences in the health status of dogs upon presentation at local veterinary clinics.
Of the SNPs identified in our dog population and our cloned English Springer Spaniel P2X7 (Fig. 7) , the R270C SNP was concluded to be a loss--of--function SNP impairing both P2X7 channel activity and pore formation. To the best of our knowledge this SNP has not been previously reported, but a R270H SNP (rs7958311) has been identified in human P2X7 and confers a partial loss of function (49) . Thus, this latter result indirectly supports the concept that R270C, which exchanges a positively charged arginine residue for a polar, uncharged cysteine residue, is a loss--of--function SNP in canine P2X7. Structural modeling of human P2X7 places the R270 residue and the neighboring R276 residue, which is the site for the R276H loss--of--function SNP (49) , in the β12 strand of the lower body of the extracellular loop and away from the ATP--binding site (27) . As such, Jiang and colleagues proposed that the R276H SNP maybe involved in conformational changes associated with channel gating or receptor activation/deactivation (27) . Thus by extension, it is possible that the R270C SNP may also act in a similar way to negatively effect P2X7 function. Alternatively, since this SNP introduces a cysteine adjacent to the existing cysteine at position 269, it is possible that the R270C SNP disrupts the potential disulfide bond between C260 and C269 (29) to reduce receptor function by altering the structure of the P2X7 subunit. Disulfide bonds of the extracellular loop of P2X7 are also essential for its trafficking to the plasma membrane (29) , however it appears unlikely that R270C SNP impairs trafficking of the canine P2X7 to the cell--surface as immunocytochemistry showed the presence of cell--surface P2X7 on HEK--293 cells expressing P2X7 containing this SNP.
The missense SNPs, F103L and R365Q, in canine P2X7 may be partial loss--of--function SNPs. However the current body of evidence is limited as total P2X7 expression was also reduced by a similar amount in HEK--293 cells transfected with either mutant P2X7 compared to cells transfected with wild--type P2X7. Thus, whether the lower P2X7 function of either mutant receptor is due to reduced P2X7 protein synthesis or half--life, or plasmid transfection efficiency remains to be determined.
In contrast to the other missense SNPs in canine P2X7, it is reasonable to conclude that the P452S SNP does not alter P2X7 function. It is noteworthy that the P452S SNP in canine P2X7 is located at the equivalent position to that of the partial loss--of--function P451L SNP in murine P2X7, which is present in some but not all mouse strains (1) . This difference in effect between canine P452S and murine P451L on P2X7 function may relate to differences between the hydrophilic and larger hydrophobic side chain of serine and leucine, respectively.
The current study involved the cloning of canine P2X7 from an English Springer Spaniel for use in site--directed mutagenesis studies to examine the effects of identified SNPs on P2X7 function. This breed was originally chosen following our original studies of endogenous P2X7 in this breed (44, 48) . Compared to wild--type canine P2X7 (NCBI Reference Sequence NM_001113456.1), the cloned English Springer Spaniel P2X7 differed by two amino acid residues, L440F and P452S. The P452S SNP had an allele frequency of 0.39 in our dog population. In contrast, the L440F SNP has not been previously reported and was not observed in any other dog for which exon 13 was sequenced (results not shown). Whether this variant represents a SNP in English Springer Spaniels or was introduced as a result of the cloning process remains unknown.
Pharmacological characterization of the recombinant English Springer Spaniel P2X7 demonstrated that this receptor displays rank orders of agonist and antagonist potencies similar to that of endogenous and recombinant human P2X7 (15, 19, 39) . Of note, the EC50 values for BzATP and ATP were similar to that described for endogenous P2X7 in erythrocytes from English Springer Spaniels (48) . Moreover, study of both endogenous P2X7 (48) and the recombinant English Springer Spaniel P2X7 revealed that ATP was a partial agonist compared to BzATP. These results contrast findings with the previously cloned canine P2X7 of Roman and colleagues, which demonstrated that BzATP was a partial agonist of canine P2X7 compared to ATP (42) . The reason for this difference between these studies remains unknown but one possible explanation is the amino acid at position 103 alters BzATP sensitivity.
In conclusion, the current study identified a missense SNP, R270C, which leads to a loss of function of canine P2X7. It will be of importance in future studies to determine the frequency of this SNP in Cocker Spaniels and other breeds, and to determine whether this SNP disrupts P2X7--mediated physiological processes, such as ATP--induced IL--1β release.
Moreover, since SNPs in the human P2RX7 gene are associated with various diseases (17, 21, 22, 32) , and that a three base--pair deletion in the gene coding the P2Y12 receptor is associated with post--operative hemorrhage in a Greater Swiss Mountain dog (8) , it will be of interest to determine whether the R270C SNP or other SNPs in the canine P2RX7 gene are associated with disease in dogs. 
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